Steve Kappenthuler

Chief Business Officer and Co-founder, Muvon Therapeutics

Steve is one of the co-founders of MUVON Therapeutics, a clinical stage Life Science spin-off from the University of Zurich developing a cell therapy platform for the regeneration of skeletal muscle tissue, and has been working with the team since 2019. With his interdisciplinary background in science and economics, Steve is responsible for the overall business and strategy development of MUVON and further supports in fundraising and organizational planning. Steve received his PhD in Chemistry and Business Studies from the University of Zurich in 2020. Between the completion of his Master’s degree (Chemistry and Business Studies UZH) and his PhD he worked for 2 Years at the Department of Management and Technology of the ETH Zurich conducting research on VC decision making and corporate venture capital.

Leonardo Royal Hotel London Tower Bridge

20 October 2022